Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery
- Conditions
- Pain
- Interventions
- Drug: Placebo
- First Posted Date
- 2016-03-18
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 156
- Registration Number
- NCT02713230
- Locations
- 🇺🇸
Horizon Research Group, Inc, Mobile, Alabama, United States
🇺🇸Denver Metro Orthopedics, Englewood, Colorado, United States
🇺🇸Fairview Hospital, Cleveland, Ohio, United States
Study to Characterize the PK and Local Extent and Duration of Exposure From FX006 in Patients With OA of the Knee
- Conditions
- Osteoarthritis of the Knee
- Interventions
- Drug: FX006 32 mgDrug: TCA IR 40
- First Posted Date
- 2015-12-22
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 81
- Registration Number
- NCT02637323
Evaluation of EXPAREL for Prolonged Postsurgical Analgesia in Subjects Undergoing Third Molar Extraction
- First Posted Date
- 2015-08-07
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 166
- Registration Number
- NCT02517905
- Locations
- 🇺🇸
Jean Brown Research, Salt Lake City, Utah, United States
Proof of Concept Study Comparing FX006 to Kenalog®-40 in Patients With Post-Traumatic Osteoarthritis of the Knee
- Conditions
- Post-traumatic Osteoarthritis of the Knee
- Interventions
- Drug: FX006 32 mgDrug: TCA IR 40 mg
- First Posted Date
- 2015-06-11
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 6
- Registration Number
- NCT02468583
- Locations
- 🇺🇸
San Antonio Military Medical Center, San Antonio, Texas, United States
Study of FX006 for the Treatment of Pain in Patients With Osteoarthritis of the Knee
- Conditions
- Osteoarthritis of the Knee
- Interventions
- First Posted Date
- 2015-02-06
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 486
- Registration Number
- NCT02357459
- Locations
- 🇺🇸
PMG Research of Cary, Cary, North Carolina, United States
🇺🇸PMG Research of Knoxville, Knoxville, Tennessee, United States
Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section
- First Posted Date
- 2015-02-03
- Last Posted Date
- 2021-03-26
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 12
- Registration Number
- NCT02353754
- Locations
- 🇺🇸
Tradition Medical Center, Port Saint Lucie, Florida, United States
🇺🇸Saint Peter's University Hospital, New Brunswick, New Jersey, United States
🇺🇸University Of Minnesota, Minneapolis, Minnesota, United States
Pharmacokinetics and Safety of Bupivacaine HCl Spinal Block and EXPAREL Local Infiltration in Total Knee Arthroplasty
- First Posted Date
- 2014-11-06
- Last Posted Date
- 2021-03-08
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 15
- Registration Number
- NCT02284386
- Locations
- 🇺🇸
University of Minnesota Medical Center - Fairview, West Bank, Minneapolis, Minnesota, United States
🇺🇸Shaols Medical Trials, Inc., Sheffield, Alabama, United States
A Randomized, Study to Evaluate the Iovera° Device in Treating Pain Associated With Total Knee Arthroplasty
- Conditions
- Arthritis of the Knee
- Interventions
- Device: iovera°Device: iovera° Sham
- First Posted Date
- 2014-11-05
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 150
- Registration Number
- NCT02284113
- Locations
- 🇺🇸
Phoenix Clinical Research, LLC, Tamarac, Florida, United States
🇺🇸LSUHSC - Department of Orthopaedics, New Orleans, Louisiana, United States
🇺🇸Holy Cross Hospital Orthopedic Research Institute, Fort Lauderdale, Florida, United States
Study to Evaluate the Iovera° Device for Temporary Relief From Knee Pain
- Conditions
- Knee Osteoarthritis
- Interventions
- Device: iovera°Device: Sham Comparator
- First Posted Date
- 2014-10-09
- Last Posted Date
- 2024-01-24
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 180
- Registration Number
- NCT02260921
- Locations
- 🇺🇸
Kansas City Bone and Joint Clinic, Overland Park, Kansas, United States
🇺🇸Kansas University Medical Center, Fairway, Kansas, United States
🇺🇸Medvin Clinical Research, Covina, California, United States
EXPAREL Infiltration in Subjects Undergoing Femoral Nerve Block With Bupivacaine HCl for Total Knee Arthroplasty
- First Posted Date
- 2014-10-02
- Last Posted Date
- 2021-03-08
- Lead Sponsor
- Pacira Pharmaceuticals, Inc
- Target Recruit Count
- 23
- Registration Number
- NCT02255500
- Locations
- 🇺🇸
Research Concepts, GP, LLC, Houston, Texas, United States